Schedule 13G ownership disclosure

Avalanche Biotechnologies, Inc.

Security class unavailable · CUSIP: 05337G107

Event date: 2016-01-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,375,602
Percent of class
5.3400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-16-004966
Form type
SC 13G
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Jan 21, 2016
Reporting period
Jan 13, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub